18th Dec 2023 13:38
(Alliance News) - EDX Medical Group PLC on Monday posted a "positive" outlook for its financial year, despite reporting a widened interim loss.
EDX Medical is a Cambridge, England-based company that develops digital diagnostic products and services for the treatment of cancer, heart disease, and infectious diseases.
In the six months ended September 30, revenue rose to GBP20,076, compared to no revenue a year earlier.
Its pretax loss widened, however, to GBP1.3 million from GBP684,854. Administrative expenses climbed to GBP1.3 million from GBP665,395.
Looking ahead EDX said the outlook for the remainder of the financial year remains "positive." It said that it now entering a new phase for the firm.
"During the reporting period, the group has continued to develop its strategy of creating innovative digital diagnostic healthcare products and services to address major diseases and enable better treatment and outcomes for patients, said Chair Jason Holt.
"The imperative for the group post this half-yearly interim reporting period remains growing our business rapidly as opportunities emerge to take forward products and projects with significant commercial potential."
By Sophie Rose, Alliance News senior reporter
Comments and questions to [email protected]
Copyright 2023 Alliance News Ltd. All Rights Reserved.
Related Shares:
Edx Medical Grp